首页> 外文期刊>Inorganica Chimica Acta >Synthesis, crystal structure, DNA cleavage and antitumor activity of two copper(II) complexes with N-sulfonamide ligand
【24h】

Synthesis, crystal structure, DNA cleavage and antitumor activity of two copper(II) complexes with N-sulfonamide ligand

机译:用N-磺酰胺配体的两种铜(II)配合物的合成,晶体结构,DNA切割和抗肿瘤活性

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Two Cu(II) complexes, [Cu(L1)(2)(py)(2)(H2O] (C1) (HL1 = N-(5-(4-methylphenyl)-[1,3,4]-thiadiazole-2-yl)-naphtalenesulfonamide) and [Cu(HL2)(4)](OH)(2) (C2) (HL2 = N-(5-(4-methoxyphenyl)-[1,3,4]-thiadiazole-2-yl)-toluenesulfonamide) with two new obtained ligands were synthesized. The X-ray crystal structures of the complexes have been determined. In the complex C1, the Cu(II) ion is five-coordinated, forming a CuN4O chromophore and in the complex C2, the Cu(II) ion is four-coordinated, forming a CuN4 chromophore. The ligands act as monodentate, coordinating the metal ion through a single N-thiadiazole atom. For the complex C1, the molecules from the reaction medium (pyridine and water) are also involved in the coordination of the Cu(II) ion. The complexes have a slightly distorted square pyramidal square-planar (C1) and a square-planar (C2) geometry. The compounds were characterized by FT-IR, electronic, EPR spectroscopic and magnetic methods. The nuclease activity studies of the synthesized complexes confirm their capacity to cleavage the DNA molecule. The results of in vitro cell cytotoxicity on three carcinoma cell lines (HeLa, A2780 and A2780cisR) are in concordance with the DNA cleavage study and with the SOD-mimetic activity and indicate that both complexes have antitumor activity. The antitumor activity was compared with Cisplatin and C1 complex demonstrated a higher activity. Both complexes overcame the Cisplatin resistance tence in A2789cisR cells whitout enhanced toxicity on normal fibroblastic cells.
机译:两个铜(II)配合物,[铜(L1)(2)(吡啶)(2)(H 2 O](C1)(HL1 = N-(5-(4-甲基苯基) - [1,3,4] - 噻二唑吡啶-2-基)-naphtalenesulfonamide)和[铜(HL2)(4)](OH)(2)(C2)(HL2 = N-(5-(4-甲氧基苯基) - [1,3,4] - 噻二唑吡啶-2-基)-toluenesulfonamide)具有两个新获得的配位体合成的。已经确定了复合物的X射线晶体结构。在复杂C1中,Cu(II)离子是五配位,从而形成发色团CuN4O和在复合体C2中,Cu(II)离子是四配位,形成一个CuN4发色团。所述配体充当单齿,协调通过单个N噻二唑原子的金属离子。对于复杂的C1,从反应介质中的分子(吡啶和水)也参与在Cu(II)离子的配位。该配合物具有轻微扭曲的四方锥正方形平面(C1)和一个正方形平面(C2)的几何形状。将化合物,其特征在于FT- IR,电子,EPR光谱和磁学方法,合成器的核酸酶活性研究esized络合物确认其以裂解DNA分子的能力。体外细胞毒性的三个癌细胞系(HeLa细胞,A2780和A2780cisR)的结果与所述DNA切割研究一致,并与SOD-模拟活性,并且表明这两种复合物具有抗肿瘤活性。的抗肿瘤活性与表现出较高的活性和顺铂C1复杂比较。两种复合克服了A2789cisR细胞whitout增强对正常成纤维细胞的毒性顺铂电阻唐塞。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号